Physician profile
Larry A Fish
NPI 1124019187
$1,163.53
in general payments reported to CMS, 2019-2025
16 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $27.27 · 2021: $268 · 2022: $249 · 2024: $114 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $232.52 | 2019-2022 | |
| Horizon Therapeutics Plc | $122.81 | 2021 | |
| Mallinckrodt Hospital Products INC. | $122.68 | 2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $98.29 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $97.40 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $97.09 | 2020-2024 | Eylea Hd |
| Novartis Pharmaceuticals Corporation | $86.75 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $65.17 | 2024-2025 | Xdemvy |
| Amgen INC. | $48.65 | 2019 | |
| Biotissue Holdings INC. | $48.63 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $44.48 | 2019 | |
| Rxsight INC | $34.21 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $21.58 | 2025 | Tyrvaya |
| Abbvie INC. | $16.61 | 2022 | |
| Allergan, INC. | $15.37 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.